share_log

Biogen | 8-K: Biogen reports fourth quarter and full year 2023 results and expects return to Non-GAAP EPS growth in 2024

SEC announcement ·  Feb 13 20:09
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.